Mental Health is wealth!

Overview

Attention-Deficit/Hyperactivity Disorder (ADHD) affects focus, organization, and impulse control. It looks different in adults than in children — restlessness gives way to chronic disorganization, time blindness, and the sense that everyone else got a manual you didn't.

Core Symptoms

Difficulty sustaining attention on tasks that don't provide immediate reward. Chronic forgetfulness and losing track of items. Starting projects with enthusiasm, then losing steam before finishing. Restlessness, fidgeting, or an internal sense of being 'revved up'. Impulsive decisions — speaking before thinking, interrupting, or snapping at small frustrations.

Management & Treatment

We start with a thorough evaluation: ruling out sleep issues, thyroid problems, anxiety, and other conditions that mimic ADHD. We map how ADHD actually shows up in your life — work, relationships, daily routines — and build a plan around that. Practical structure matters: external reminders, body-doubling, and breaking tasks into smaller steps. We coordinate with therapists who specialize in adult ADHD.

Medication is the most evidence-based tool for ADHD — stimulants (methylphenidate, amphetamine-based) and non-stimulants (atomoxetine, guanfacine, viloxazine). Most patients describe the first dose as 'putting on glasses' — the mental static quiets. We start low, titrate carefully, and monitor side effects (sleep, appetite, mood). Many adults do well on medication alone. For others, we combine it with skills coaching around time management, organization, and emotional regulation. Our goal isn't to change who you are — it's to remove the friction that's been getting in your way.

Overview

Anxiety disorders are among the most common — and most treatable — reasons people seek psychiatric care. Generalized anxiety, social anxiety, panic, and phobias all share one thing: a nervous system stuck in overdrive. Anxiety isn't a character flaw, and it isn't 'just stress.' It's a treatable medical condition.

Core Symptoms

Persistent worry that won't shut off, even when things are going well. Physical symptoms: racing heart, chest tightness, shortness of breath, muscle tension, stomach issues. Sleep disruption — trouble falling asleep, waking at 3am with your mind racing. Avoidance of situations that trigger anxiety (which often makes the anxiety bigger over time). Difficulty concentrating because of background worry.

Management & Treatment

We start by understanding the type of anxiety: generalized, social, panic, or specific phobias. Each has slightly different treatment paths. We rule out medical causes (thyroid, caffeine, medications) and assess for co-occurring conditions like depression or ADHD that often travel with anxiety. Lifestyle factors matter: sleep hygiene, reducing stimulants, regular movement. We coordinate with therapists who do CBT, exposure therapy, or ACT.

First-line medications include SSRIs (sertraline, escitalopram, paroxetine) and SNRIs (venlafaxine, duloxetine). These take 4-6 weeks to reach full effect. For acute anxiety, we may use a short course of a benzodiazepine while waiting for the SSRI to work, or a medication like hydroxyzine or a beta-blocker for physical symptoms. Buspirone is another option for generalized anxiety. Most patients see meaningful improvement within 2-3 months. The combination of medication plus therapy (especially exposure-based CBT) gives the best long-term results.

Overview

Obsessive-Compulsive Disorder involves intrusive thoughts and repetitive behaviors that feel impossible to switch off — and that often don't match the person's actual values or fears. It's not about being 'particular' or 'clean.' OCD is a recognized medical condition with specific neurological patterns, and it responds well to targeted treatment.

Core Symptoms

Intrusive thoughts, images, or urges that feel intrusive, unwanted, and distressing (contamination, harm, symmetry, forbidden thoughts). Compulsions — repetitive behaviors or mental acts performed to neutralize the anxiety (washing, checking, counting, mental reviewing). Insight that the thoughts are excessive, but inability to stop. Significant time consumption (more than 1 hour/day) or marked distress/impairment. Ego-dystonic nature: 'these thoughts are not me.'

Management & Treatment

We do a detailed assessment to distinguish OCD from OCPD (personality traits), anxiety disorders, or autism-spectrum rigidity. We screen for common comorbidities: depression, anxiety, tic disorders. Family education matters — OCD often involves accommodation by family members, which maintains the cycle. We coordinate with therapists trained in Exposure and Response Prevention (ERP), the gold-standard therapy. We assess for PANS/PANDAS in pediatric onset cases.

First-line medications are SSRIs at higher doses than used for depression: fluoxetine 60-80mg, sertraline 150-200mg, fluvoxamine 200-300mg. These take 8-12 weeks for full effect. Clomipramine (a tricyclic) is also effective but has more side effects. For treatment-resistant cases, we may add an atypical antipsychotic (risperidone, aripiprazole) as augmentation. The combination of SSRI + ERP therapy gives the best outcomes. Treatment takes patience, but most people with OCD see real, durable improvement.

Overview

Panic disorder involves recurrent, unexpected panic attacks — sudden waves of intense fear that peak within minutes — followed by persistent worry about having more attacks. It's not 'just anxiety.' A panic attack can feel like a heart attack, and the fear of having another can reshape your entire life around avoidance.

Core Symptoms

Sudden episodes of intense fear with physical symptoms: racing or pounding heart, chest pain, shortness of breath, sweating, trembling, dizziness, numbness, feeling of choking. Intense fear of losing control, going crazy, or dying. Persistent worry between attacks about when the next one will happen. Avoidance of places or situations where attacks have occurred (driving, crowds, exercise). Agoraphobia can develop in severe cases.

Management & Treatment

We first rule out cardiac and respiratory causes of the physical symptoms (EKG, basic labs). We educate about what panic attacks are: a false alarm from the fight-or-flight system, not a sign of danger. We assess for agoraphobia severity. We coordinate with therapists who do interoceptive exposure (learning that physical sensations are not dangerous) and in vivo exposure for avoided situations. We screen for substance use — caffeine and stimulants can trigger attacks.

First-line medications are SSRIs (sertraline, paroxetine, escitalopram) — same as for other anxiety disorders. These reduce attack frequency and the anticipatory anxiety. Benzodiazepines (alprazolam, clonazepam) work quickly for acute attacks but are generally not first-line for chronic management due to dependence risk. For breakthrough attacks, a short-acting medication can be used sparingly. The combination of SSRI + CBT with exposure components gives the best long-term outcomes. Most patients achieve significant reduction in attack frequency within 2-3 months.

Overview

Bipolar disorder involves real shifts in mood, energy, and sleep — not just 'mood swings.' The depressive episodes are usually what bring people in, but understanding the full pattern is what makes treatment work. With the right plan, most people with bipolar live fully and predictably.

Core Symptoms

Distinct episodes: depressive (low mood, anhedonia, fatigue, sleep changes) and manic/hypomanic (elevated or irritable mood, decreased need for sleep, racing thoughts, grandiosity, increased goal-directed activity, risk-taking behavior). Episodes last days to weeks, not hours. Between episodes, mood can be normal. Bipolar II involves hypomania (less severe) with full depressive episodes. Pattern often emerges in late teens/early 20s.

Management & Treatment

We take a careful history: when did mood episodes start? How long do they last? Any triggers? We use screening tools (MDQ, BSDS) and often ask patients to track mood/sleep in a daily log. We coordinate with therapists who understand bipolar — standard talk therapy alone can sometimes worsen mania. We screen for substance use, which commonly co-occurs. Family history is informative. We assess for rapid cycling (4+ episodes/year) which changes treatment.

Mood stabilizers are the foundation: lithium (gold standard, also reduces suicide risk), valproate, carbamazepine, lamotrigine (especially for bipolar depression). Atypical antipsychotics are also first-line: quetiapine, lurasidone (for bipolar depression), olanzapine-fluoxetine combination. Many patients need combination therapy. Antidepressants are used cautiously and almost always with a mood stabilizer, to avoid triggering mania. Sleep stability is non-negotiable. Treatment is long-term, often lifelong, with regular monitoring of levels (for lithium, valproate) and metabolic markers (for atypicals).

Overview

Post-Traumatic Stress Disorder develops after exposure to actual or threatened death, serious injury, or violence. It's a real injury to the nervous system, not a sign of weakness. After trauma, the brain's threat-detection system gets stuck 'on,' and the body responds as if the danger is still happening.

Core Symptoms

Intrusive memories: flashbacks, nightmares, distressing thoughts that feel like reliving the event. Avoidance: staying away from places, people, or activities that remind you of the trauma. Negative changes in mood and cognition: guilt, shame, emotional numbness, feeling detached from others, negative beliefs about self or world. Hyperarousal: being easily startled, always on guard, sleep problems, irritability, difficulty concentrating. Symptoms last more than one month and cause significant impairment.

Management & Treatment

We start with thorough assessment: what was the trauma, when, how has it affected functioning? We screen for comorbidities: depression, substance use, anxiety, dissociation. Safety is the first priority — we assess for self-harm risk. We coordinate with therapists trained in trauma-focused therapies: EMDR (Eye Movement Desensitization and Reprocessing), TF-CBT (Trauma-Focused CBT), Prolonged Exposure (PE), or CPT (Cognitive Processing Therapy). We pace the work — trauma processing shouldn't begin until stabilization.

First-line medications are SSRIs (sertraline, paroxetine) and the SNRI venlafaxine — these have the strongest evidence for PTSD. Prazosin can help with trauma-related nightmares. For treatment-resistant cases, we may consider augmentation with atypical antipsychotics. MDMA-assisted therapy is in late-stage trials and showing promising results. The goal isn't to forget what happened — it's to live fully again without the past running the show. Treatment takes time, but most people see meaningful improvement.

Overview

Depression isn't sadness, and it isn't weakness. It's a treatable medical condition that affects how you think, sleep, eat, and connect. Major depression affects how the brain regulates mood, motivation, and pleasure — and it responds to specific treatments that target those systems.

Core Symptoms

Persistent low mood or loss of interest/pleasure in activities you used to enjoy (anhedonia). Sleep changes: insomnia (trouble staying asleep) or hypersomnia (sleeping 10+ hours and still feeling tired). Appetite/weight changes. Fatigue and low energy, even with rest. Difficulty concentrating, making decisions, or remembering. Feelings of worthlessness or excessive guilt. Recurrent thoughts of death or suicide. Symptoms last at least 2 weeks and represent a change from previous functioning.

Management & Treatment

We do a full assessment: when did symptoms start? Any triggers? Medical history, medications, substance use, family history. We rule out medical causes: thyroid disorders, vitamin D/B12 deficiency, sleep apnea, chronic pain conditions. We assess severity and suicide risk at every visit. We coordinate with therapists who do CBT, behavioral activation, or IPT (Interpersonal Therapy). We discuss whether medication, therapy, or both is the right starting point — depending on severity and patient preference.

First-line antidepressants are SSRIs (sertraline, escitalopram, fluoxetine) and SNRIs (venlafaxine, duloxetine). These take 4-6 weeks to reach full effect, and we may need to adjust dose or switch medications. For treatment-resistant depression, we consider augmentation strategies: aripiprazole, brexpiprazole, bupropion, or lithium. Esketamine (Spravato) and TMS (Transcranial Magnetic Stimulation) are options for treatment-resistant cases. For depression with seasonal pattern, bupropion XL can prevent winter episodes. Many patients start feeling meaningfully better within weeks, and we keep close follow-up until you're stable.

Overview

Psychosis is a treatable condition that affects how the brain processes perception and thought — sometimes involving hallucinations, delusions, or disorganized thinking. First-episode care matters a lot: early, consistent treatment improves long-term outcomes dramatically.

Core Symptoms

Positive symptoms: hallucinations (hearing voices, seeing things others don't), delusions (fixed false beliefs that don't respond to logic), disorganized speech or behavior. Negative symptoms: flat affect, reduced speech, loss of motivation, social withdrawal. Cognitive symptoms: difficulty with attention, memory, and problem-solving. Symptoms cause significant impairment in functioning. First episode is typically in late teens to early 30s for primary psychotic disorders, though it can occur at any age.

Management & Treatment

We do a thorough evaluation to determine the cause: primary psychotic disorder (schizophrenia, schizoaffective, bipolar with psychotic features), substance-induced, medical cause (seizure, tumor, autoimmune), or brief psychotic episode. We assess duration: less than 1 month = brief psychotic disorder; 1-6 months = schizophreniform; more than 6 months = schizophrenia. We screen for substance use — cannabis, stimulants, and hallucinogens can trigger psychotic episodes. We coordinate with case management, supported employment, and family education programs (like NAVIGATE for first-episode psychosis).

Antipsychotic medications are the foundation. Second-generation (atypical) antipsychotics are typically first-line due to better side-effect profiles: risperidone, olanzapine, quetiapine, aripiprazole, paliperidone, lurasidone, ziprasidone. For treatment-resistant cases, clozapine is the gold standard and uniquely reduces suicide risk. Long-acting injectables (Risperdal Consta, Invega Sustenna, Abilify Maintena) are excellent options for adherence. We monitor metabolic side effects (weight, glucose, lipids) and movement side effects (tardive dyskinesia). The combination of medication, family support, and psychosocial interventions gives the best long-term outcomes. Recovery is real and common.